Qiming Venture Partners

🔊 Looking back, what Qiming Venture Partners has achieved? Find out more in 60 seconds.

By the end of August 2024, the "Yunshang Weiyi" project, supported by our portfolio company Zuoshou Yisheng's AI-powered family doctor service, had registered over 190,000 users within just two months of its launch in Zhongwei, Ningxia province. This project offers residents 24/7 AI family doctor services, providing multi-disciplinary consultation recommendations based on their individual health conditions. By facilitating cross-disciplinary collaboration, the AI system addresses complex medical issues and delivers personalized health solutions. It also updates health records in real time, assisting human doctors in maintaining up-to-date and individualized patient care. As a successful example of smart healthcare, the "Yunshang Weiyi" project not only improves the efficiency and quality of healthcare services but also makes premium medical care more accessible at the community level, ensuring that everyone benefits from convenient, high-quality healthcare. #SmartHealthcare #AIinMedicine #DigitalHealth #PersonalizedCare #HealthcareInnovation #HealthTech #QimingPortfolio #QimingHealthcare

SinoUnited Health's Pink Ribbon Public Welfare Month, celebrated every October, is dedicated to empowering modern women to confront and address their health challenges. This initiative embodies the core mission of the company's Women's Health Center, which is committed to spreading health awareness and providing comprehensive medical services throughout every stage of a woman's life. In line with this commitment, SinoUnited Health has launched a special breast screening package that emphasizes the importance of early detection, diagnosis, and treatment of breast cancer. Regular screenings are crucial for identifying early-stage breast cancer and significantly improve cure rates and survival chances. Additionally, SinoUnited Health will partner with various organizations to host a lecture series focused on women's health management. The company invites women to join its upcoming seminar in Shanghai's Lujiazui area, where medical experts will share insights on holistic health management and how to effectively address breast health issues in the context of advancing medical technologies. #PinkRibbonMonth #WomensHealth #BreastScreening #HealthAwareness #EarlyDetection #EmpowerWomen #HealthManagement #QimingPortfolio #QimingHealthcare

Abbisko Therapeutics (SEHK:2256) has published the Phase 3 study design of Pimicotinib in Future Oncology. This MANEUVER study is a Phase 3, randomized, placebo-controlled, double-blind, multi-region trial consisting of three parts. In Part 1, eligible participants are randomized in a 2:1 ratio to receive either pimicotinib 50 mg QD or a matching placebo for 24 weeks (28-day cycles). Part 2 is an open-label treatment phase, during which all participants will receive open-label pimicotinib until they complete 24 weeks of dosing or withdraw from the study. Participants who complete Part 2 will have the option to enter the open-label extension treatment phase, referred to as Part 3, which facilitates prolonged treatment. Additionally, upon completion of Part 1, patients will be invited by the investigator to participate in an optional qualitative interview to assess their perspective on clinical efficacy. The MANEUVER study is the first global trial to enroll both Asian and Western patients with TGCT in balanced proportions across China and countries in North America and Europe. #Pimicotinib #MANEUVERStudy #ClinicalTrials #FutureOncology #TGCT #HealthcareInnovation #OncologyResearch #PatientEngagement #QimingPortfolio #QimingHealthcare Read More: https://lnkd.in/gimuAKd9

DP Technology has launched Uni-AIMS, an AI-driven intelligent microscopy image analysis software. As a smart tool for industrial analysis and quality control, Uni-AIMS uses deep learning to automatically recognize objects in microscopy images and perform detailed characterization calculations, outputting comprehensive statistical reports that support scientific research and industrial production. The AI engine of Uni-AIMS employs the latest technology to achieve high-precision automatic recognition of targets in microscopy images, completing high-precision analysis without human intervention. This enhances the level of automation and intelligence in image analysis, significantly improving both efficiency and accuracy. To meet the growing demand for lightweight deployment and localized data processing, DP Technology has also introduced an all-in-one functionality package, providing a seamless plug-and-play experience. Uni-AIMS is set to accelerate scientific research in new materials and pharmaceuticals, offering valuable insights for production quality assessment and optimization. #Innovation #DeepLearning #ElectronMicroscopy #DataAnalysis #NewMaterials #Pharmaceuticals #QualityAssurance #SmartManufacturing #QimingPortfolio #QimingHealthcare

Our portfolio company Just Medical has received NMPA approval for its cementless unicompartmental knee system, completing its product line, which includes mobile-bearing, hybrid fixation, and fixed-bearing unicompartmental knee systems. This milestone strengthens Just Medical's ability to meet the diverse treatment needs of osteoarthritis patients. Unicompartmental knee systems are a key solution for advanced knee disease, with proven clinical outcomes and recognition from orthopedic surgeons globally. While most available options are cemented, Just Medical is leading the way by launching the cementless unicompartmental knee system—offering more personalized solutions for patients. #MedicalInnovation #Orthopedics #Osteoarthritis #KneeReplacement #BiologicProsthesis #Healthcare #NMPAApproval #QimingPortfolio #QimingHealthcare

Check out the exciting news from Hesai Technology (NASDAQ: HSAI) as the company officially opened its Columbus South China Operations Center in Guangzhou. This new hub will play a critical role in driving Hesai Technology's business expansion, customer innovation, and operational strategies. By leveraging local resources, advancing business processes, and fostering innovative partnerships, the center is set to become a key engine for Hesai Technology's future growth. The center also marks a new strategic milestone for Hesai Technology in South China. Located in the heart of Guangzhou's Zhujiang New Town CBD, it is poised to strengthen the company's global presence and deepen its regional operations. It will serve as a key driver in expanding the company's business horizons, supporting the rapid growth of the global autonomous driving industry, and reinforcing Hesai Technology's commitment to advancing smart mobility technologies. #TechnologyInnovation #Lidar #AutonomousDriving #SmartCities #BusinessGrowth #NASDAQ #Guangzhou #InnovationLeadership #QimingPortfolio #QimingTechnology

At Wonder Festival 2024, 52TOYS showcased an exciting array of new products from several popular series, including MECHA & MODEL KITS and ACTION FIGURES. The event also highlighted collaborations with various renowned artists. Among the featured products was the beloved BEASTBOX series, which introduced new figures such as a 7 cm mammoth, a 5 cm giraffe, and a 4 cm penguin. The ACTION FIGURES line offers a variety of products, including highly anticipated blind box collections from the classic animation The Legend of Sealed Book. An original series titled "World Celebrities," featuring iconic figures from human history, also made a notable appearance. #WonderFestival #ToyCollectibles #MECHAKits #ActionFigures #BEASTBOX #BlindBoxes #ToyInnovation #ArtCollaboration #PopCulture #QimingPortfolio #QimingConsumer

Our portfolio company, ZD Medical Inc., has officially received registration approval for its comprehensive intelligent diagnostic OCT (Basic Version), Luminor-D60M. Designed to address the essential needs of primary eye care, this innovative OCT system enhances the diagnostic capabilities of grassroots ophthalmology institutions for retinal diseases. Notably, it is the only basic OCT in the Chinese market that combines AI-assisted screening with remote image interpretation by experts. #OCT #HealthcareInnovation #EyeCare #MedicalTechnology #Diagnostics #RetinalDisease #PrimaryCare #QimingPortfolio #QimingHealthcare

Aohua Endoscopy Co., Ltd. (SHSE: 688212) has announced the official launch of its AQ-150 Series 4K Ultra HD Endoscopy System and AQ-120 Endoscopy System. The AQ-150 Series features a 10.1-inch touch LCD screen and an intuitive interface that simplifies operations. Equipped with the STCE submucosal texture enhancement algorithm, it enhances mucosal color, texture, and brightness, improving the visibility of potential lesions. With future optical magnification up to 140x, it delivers distortion-free, highly detailed images, helping clinicians accurately diagnose and assess conditions across multiple specialties. The AQ-120 Series, with its compact, all-in-one design, is perfect for diverse clinical settings, particularly in primary care. It offers excellent compatibility with a wide range of gastrointestinal, bronchial, and ENT endoscopes, making it highly versatile and expanding its application across different medical needs. #4KEndoscopy #MedicalTechnology #HealthcareInnovation #EndoscopySolutions #ClinicalDiagnostics #MedicalDevices #QimingPortfolio #QimingHealthcare